India to Australia: Cytarabine Export Trade Route
India has recorded 4 verified shipments of Cytarabine exported to Australia, representing a combined trade value of $517.7K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $129.4K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED , which accounts for 92% of total export value with 1 shipments worth $475.8K USD. On the buying side, ACCORD HEALTHCARE PTY LTD is the largest importer in Australia with $475.8K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, KINGS GLOBAL BIOTECH LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Cytarabine corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $517.7K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED , which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's cytarabine manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $129.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with cytarabine's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 15.9%, placing it at rank #15 among India's top cytarabine export destinations globally.
On the import side, key buyers of Indian cytarabine in Australia include ACCORD HEALTHCARE PTY LTD , XXIZEXXSERXXCE XXMPAXX BV, PFIZER SERVICE COMPANY BV and 1 others. ACCORD HEALTHCARE PTY LTD is the single largest importer with 1 shipments valued at $475.8K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portAHEMDABAD AIR ACC (INAMD4)
Market Position
- Global rank#15
- Annual growth+15.9%
- Demand growth+15.6%
- Regulatory ease82/100
Top 10 Indian Cytarabine Exporters to Australia
Showing top 10 of 3 Indian suppliers exporting Cytarabine to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $475.8K per shipment | 1 | $475.8K | 91.9% |
| 2 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED Avg $21.0K per shipment | 2 | $41.9K | 8.1% |
| 3 | KINGS GLOBAL BIOTECH LIMITED Avg $60 per shipment | 1 | $60 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting cytarabine to Australia, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED , ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, KINGS GLOBAL BIOTECH LIMITED. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 1 shipments worth $475.8K USD, giving it a 92% market share.
Top 10 Cytarabine Importers in Australia
Showing top 10 of 4 known buyers in Australia receiving Cytarabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cytarabine in Australia include ACCORD HEALTHCARE PTY LTD , XXIZEXXSERXXCE XXMPAXX BV, PFIZER SERVICE COMPANY BV, TO THE IMPORT MANAGER. The largest importer is ACCORD HEALTHCARE PTY LTD , accounting for $475.8K USD across 1 shipments — representing 92% of all cytarabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE PTY LTD | 1 | $475.8K | 91.9% |
| 2 | XXIZEXXSERXXCE XXMPAXX BV | 1 | $21.0K | 4.1% |
| 3 | PFIZER SERVICE COMPANY BV | 1 | $20.9K | 4.0% |
| 4 | TO THE IMPORT MANAGER | 1 | $60 | 0.0% |
Top 10 Cytarabine Formulations Imported by Australia
Showing top 10 of 3 product formulations shipped on the India to Australia Cytarabine route, ranked by trade value
Australia imports a wide range of cytarabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS AND MEDI CYTARABINE ACCORD — accounts for $475.8K USD across 1 shipments. A total of 3 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS AND MEDI CYTARABINE ACCORD | 1 | $475.8K | 91.9% |
| 2 | CYTARABINE INJ. 2G AU - F000046298 | 2 | $41.9K | 8.1% |
| 3 | PRAMACEUTICAL PRODUCTS FOR HUMAN USE- CYTASTED 500MG/5ML INJ,MOLECULE- CYTARABINE,BATCH NO- OI240074A | 1 | $60 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD AIR ACC (INAMD4) handles the highest volume with 1 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's cytarabine exports to Australia are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, KINGS GLOBAL BIOTECH LIMITED — together account for 100% of total trade value on this route. The average shipment value of $129.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as cytarabine inj. 2g au - f000046298 and pramaceutical products for human use- cytasted 500mg/5ml inj,molecule- cytarabine,batch no- oi240074a, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD HEALTHCARE PTY LTD is the largest importer with 1 shipments worth $475.8K USD — representing 92% of all cytarabine imports from India on this route.
Route Statistics
- Trade Volume
- $517.7K
- Avg. Shipment
- $129.4K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~15 days
- Annual Growth
- +15.9%
Related Analysis
Reverse Direction
Australia → India — Cytarabine (Import)Other Cytarabine Routes
Unlock the Full India to Australia Cytarabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to Australia Cytarabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cytarabine to Australia?
The leading Indian exporters of Cytarabine to Australia are INTAS PHARMACEUTICALS LIMITED , ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, KINGS GLOBAL BIOTECH LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 92% of total trade value on this route.
Q What is the total value of Cytarabine exports from India to Australia?
India exports Cytarabine to Australia worth approximately $517.7K USD across 4 recorded shipments. The average value per shipment is $129.4K USD.
Q Which ports does India use to ship Cytarabine to Australia?
The most active port of origin is AHEMDABAD AIR ACC (INAMD4) with 1 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Australia for Cytarabine?
The average transit time for Cytarabine shipments from India to Australia is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Australia Cytarabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.9% with demand growth tracking at 15.6%. The route is ranked #15 among India's top Cytarabine export destinations globally.
Q How many suppliers are active on the India to Australia Cytarabine route?
There are currently 3 active Indian suppliers exporting Cytarabine to Australia. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 92% of total shipment value.
Q Who are the main importers of Cytarabine from India in Australia?
The leading importers of Indian Cytarabine in Australia include ACCORD HEALTHCARE PTY LTD , XXIZEXXSERXXCE XXMPAXX BV, PFIZER SERVICE COMPANY BV, TO THE IMPORT MANAGER. ACCORD HEALTHCARE PTY LTD is the largest buyer with 1 shipments worth $475.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Cytarabine.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists